Granulocyte-macrophage colony-stimulating factor in the treatment of neonates with neutropenia and sepsis

Pediatric Hematology and Oncology

Volumn 17, Issue 6, 2000, Pages 469-473

  Venkateswaran, Lakshmi ^a   Wilimas, Judith A ^a,b   Dancy, Rhonda ^a   Wang, Winfred C ^a,b   Korones, Sheldon ^b,c   Hayden, Jane ^c   Hayes, F Ann ^d  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c Newborn Center   (United States)

^d AMGEN INC   (United States)

Author keywords

GM CSF; Neonate; Neutropenia; Sepsis

Indexed keywords

C REACTIVE PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ARTICLE; BLOOD CULTURE; CELL COUNT; CLINICAL ARTICLE; DRUG EFFICACY; HUMAN; NECROTIZING ENTEROCOLITIS; NEUTROPENIA; NEWBORN; NEWBORN DISEASE; NEWBORN MORTALITY; SEPSIS; SEPTIC SHOCK;

EID: 0033863641     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010050120827     Document Type: Article

References (13)

1. Neonatal sepsis
2. Cytokines in the management of infectious complications in children with cancer
3. Cytokine treatment of aplastic anemia
4. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birth weight neonates: Significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils
5. A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates
6. Early diagnosis of neonatal sepsis
7. Use of hematopoietic cytokines in combination with antibiotics in neonatal sepsis: A review of the role of adjunctive therapy in the management of neonatal sepsis
8. Decreased stimulated GM-CSF production and GM-CSF gene expression but normal numbers of GM-CSF receptors in human term newborns compared with adults
9. Transcriptional rates of granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, interleukin-3 and macrophage colony-stimulating factor genes in activated cord vs. adult mononuclear cells: Alteration in cytokine expression may be secondary to post-transcriptional instability
10. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: Significant induction of peripheral and bone marrow neutrophilia
11. Updates on cells and cytokines: The therapeutic use of hematopoietic growth factors
12. Myeloid colony-stimulating factors: Use in the newborn
13. Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of febrile neutropenia: A double blind placebo-controlled study in children